Keyword Suggestions

Results
 
 
Account Login
 
Username
 
 
 
Password
 
 
 
 
 

Library Navigation
 
 

Browse Conferences
 
 
 
22 Results Found, Showing 1 - 22
Sort By:
View:
Filter By:
Date/Time
Conference
Keyword
My Content
Start Date/Time:
End Date/Time:
 
Go
 
Conference
 
Keywords:
Click here to clear this filter
 
 
Go
Show only the content that I own
 
 
October 17, 2009 - Saturday
 
SA04 - Latest Targeted Therapies for Breast Cancer 
Relevancy:
51.29% 
 
Date/Time:
October 17, 2009   9:55am - 10:30am
 
Length:
31m 03s - 45 Slides  
 
Total Credits:
0.50 CME  
 
Speaker:
Ruth O'Regan, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA04 - Latest Targeted Therapies for Breast Cancer 
Relevancy:
51.29% 
 
Date/Time:
October 17, 2009   9:55am - 10:30am
 
Length:
31m 03s - 45 Slides  
 
Speaker:
Ruth O'Regan, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA11 - The Future of Oncology - Drugs in the Pipeline 
Relevancy:
100.00% 
 
Date/Time:
October 17, 2009   3:35pm - 4:10pm
 
Length:
43m 03s - 31 Slides  
 
Total Credits:
0.50 CME  
 
Speaker:
Bruce A. Chabner, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA11 - The Future of Oncology - Drugs in the Pipeline 
Relevancy:
100.00% 
 
Date/Time:
October 17, 2009   3:35pm - 4:10pm
 
Length:
43m 03s - 31 Slides  
 
Speaker:
Bruce A. Chabner, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
September 24, 2009 - Thursday
 
rating
HM101 - Treatment of Newly Diagnosed Myeloma in Non-transplant Candidates 
Relevancy:
56.23% 
 
Date/Time:
September 24, 2009   1:00pm - 1:30pm
 
Length:
18m 27s - 28 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Sagar Lonial, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
HM104 - Future Directions in Myeloma 
Relevancy:
79.17% 
 
Date/Time:
September 24, 2009   2:45pm - 3:15pm
 
Length:
40m 52s - 49 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Kenneth Anderson (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
A107 - Germ Cell Tumors 
Relevancy:
49.78% 
 
Date/Time:
September 24, 2009   3:40pm - 4:00pm
 
Length:
27m 14s - 58 Slides  
 
Total Credits:
0.25 CME/CE  
 
Speaker:
Craig R. Nichols, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
S103 - Current Best Practices in the Multidisciplinary Management of GIST 
Relevancy:
43.11% 
 
Date/Time:
September 24, 2009   5:10pm - 5:40pm
 
Length:
21m 57s - 52 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Robert G. Maki, MD, PhD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
September 25, 2009 - Friday
 
B201 - Neoadjuvant Therapy for Breast Cancer: Lessons Learned and New Directions with Targeted Therapeutics 
Relevancy:
38.13% 
 
Date/Time:
September 25, 2009   8:50am - 9:20am
 
Length:
25m 58s - 49 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Laura J. Esserman, MD, MBA (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
B202 - New Directions in the Treatment of 'Triple Negative' Breast Cancer 
Relevancy:
77.02% 
 
Date/Time:
September 25, 2009   9:25am - 9:55am
 
Length:
31m 46s - 41 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Lee S. Schwartzberg, MD, FACP (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
GY203 - Debate: All Patients at High Risk for Ovarian Cancer Should Undergo Routine Screening 
Relevancy:
88.08% 
 
Date/Time:
September 25, 2009   1:30pm - 2:00pm
 
Length:
41m 26s - 51 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speakers:
Michael J. Birrer, MD, PhD (Speaker Disclosure)
 
Beth Y. Karlan, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
B204 - Adjuvant Chemotherapy for Breast Cancer: Are Anthracyclines Out? 
Relevancy:
57.70% 
 
Date/Time:
September 25, 2009   2:05pm - 2:35pm
 
Length:
32m 37s - 28 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Julie R. Gralow, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
GY206 - A Rational Approach to the Use of Systemic Therapy in Recurrent or Persistent Ovarian Carcinoma 
Relevancy:
49.08% 
 
Date/Time:
September 25, 2009   4:05pm - 4:35pm
 
Length:
36m 03s - 49 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Thomas Herzog, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
HM206 - How I Manage Relapsed NHL - What and When 
Relevancy:
43.18% 
 
Date/Time:
September 25, 2009   4:05pm - 4:35pm
 
Length:
29m 35s - 47 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
David G. Maloney, MD, PhD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
GY207 - Debate: Therapy for the Patient with Platinum-Resistant/Refractory Recurrent Ovarian Carcinoma Should be Selected Based on the Results of an In Vitro Extreme Drug Sensitivity/Resistance Assay 
Relevancy:
53.74% 
 
Date/Time:
September 25, 2009   4:40pm - 5:10pm
 
Length:
25m 13s - 76 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speakers:
Michael J. Birrer, MD, PhD (Speaker Disclosure)
 
Bradley J. Monk, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
September 26, 2009 - Saturday
 
HM301 - CLL Treatment: Do Pre-treatment Characteristics Guide Current Treatment Choices? 
Relevancy:
41.69% 
 
Date/Time:
September 26, 2009   8:15am - 8:45am
 
Length:
22m 28s - 41 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Neil E. Kay, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SC301 - Vitamin D 
Relevancy:
77.93% 
 
Date/Time:
September 26, 2009   8:15am - 8:45am
 
Length:
47m 47s - 36 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Joan M. Lappe, PhD, RN, FAAN (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
HM303 - AML Therapy in the "Molecular Genetic" Era: How Does it Impact Therapeutic Approach? 
Relevancy:
52.71% 
 
Date/Time:
September 26, 2009   9:25am - 9:55am
 
Length:
40m 03s - 41 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Richard Stone, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
L304 - Current Status of Targeted Therapies in Lung Cancer 
Relevancy:
46.39% 
 
Date/Time:
September 26, 2009   1:30pm - 2:00pm
 
Length:
38m 36s - 54 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Scott Gettinger, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
L305 - What is New in Radiotherapy and the Management of NSCLC? 
Relevancy:
96.69% 
 
Date/Time:
September 26, 2009   2:05pm - 2:35pm
 
Length:
21m 49s - 50 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Quynh-Thu Le, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
GI307 - Adjuvant and Neoadjuvant Approaches for Localized Pancreatic Cancer 
Relevancy:
43.03% 
 
Date/Time:
September 26, 2009   4:05pm - 4:35pm
 
Length:
56m 59s - 50 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Douglas B. Evans, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
GI308 - Emerging Drugs in Pancreatic Cancer 
Relevancy:
44.58% 
 
Date/Time:
September 26, 2009   4:40pm - 5:10pm
 
Length:
35m 18s - 40 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Andrew H. Ko, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
22 Results Found, Showing 1 - 22